Plasma MOTS-c levels are associated with insulin sensitivity in lean but not in obese individuals
JOURNAL OF INVESTIGATIVE MEDICINE
dc.creator | Cataldo-Bascuñán, Luis Rodrigo | |
dc.creator | Fernández-Verdejo, Rodrigo | |
dc.creator | Santos-Martin, José Luis | |
dc.creator | Galgani, José Eduardo | |
dc.date | 2021-08-23T22:48:24Z | |
dc.date | 2022-07-08T20:19:00Z | |
dc.date | 2021-08-23T22:48:24Z | |
dc.date | 2022-07-08T20:19:00Z | |
dc.date | 2018 | |
dc.date.accessioned | 2023-08-22T05:35:27Z | |
dc.date.available | 2023-08-22T05:35:27Z | |
dc.identifier | 1150416 | |
dc.identifier | 1150416 | |
dc.identifier | https://hdl.handle.net/10533/250142 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8324746 | |
dc.description | Mitochondrial open reading frame of the 12S rRNA-c (MOTS-c) is a mitochondrial-derived peptide that attenuates weight gain and hyperinsulinemia when administered to high fat-fed mice. MOTS-c is therefore a potential regulator of metabolic homeostasis under conditions of high-energy supply. However, the effect of insulin resistance and obesity on plasma MOTS-c concentration in humans is unknown. To gain insight into MOTS-c regulation, we measured plasma MOTS-c concentration and analyzed its relationship with insulin sensitivity surrogates, in lean and obese humans (n=10 per group). Obese individuals had impaired insulin sensitivity as indicated by low Matsuda and high Homeostatic Model Assessment (HOMA) indexes. Although plasma MOTS-c concentration was similar in lean and obese individuals (0.48 +/- 0.16 and 0.52 +/- 0.15 ng/ml; p=0.60), it was correlated with HOMA (r=0.53; p<0.05) and Matsuda index (r=-0.46; p<0.05). Notably, when the groups were analyzed separately, the associations remained only in lean individuals. We conclude that plasma MOTS-c concentration is unaltered in human obesity. However, MOTS-c associates positively with insulin resistance mostly in lean individuals, indicating that plasma MOTS-c concentration depends on the metabolic status in this population. Such dependence seems altered when obesity settles. The implications of plasma MOTS-c for human metabolic homeostasis deserve future examination. | |
dc.description | Regular 2015 | |
dc.description | FONDECYT | |
dc.description | FONDECYT | |
dc.language | eng | |
dc.relation | handle/10533/111557 | |
dc.relation | handle/10533/111541 | |
dc.relation | handle/10533/108045 | |
dc.relation | https://doi.org/10.1136/jim-2017-000681 | |
dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Chile | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.rights | info:eu-repo/semantics/article | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Plasma MOTS-c levels are associated with insulin sensitivity in lean but not in obese individuals | |
dc.title | JOURNAL OF INVESTIGATIVE MEDICINE | |
dc.type | Articulo | |
dc.type | info:eu-repo/semantics/publishedVersion |